According to a report “Cardiovascular Repair And Reconstruction Devices Market Size, Share & Trends Analysis Report By Product (Heart Valve Repair, Graft, Patches), By Region, And Segment Forecasts, 2018 – 2025” published by Grand View Research, Inc, The global cardiovascular repair and reconstruction devices market is expected to reach USD 4,481.5 million by 2025, according to a new report by Grand View Research, Inc. Increase in the prevalence of Congenital Heart Defects (CHDs) and the availability of technologically advanced cardiovascular valves, grafts, and patches are among key factors expected to drive growth over the forecast period.
Key Takeaways from the report:
- The cardiovascular grafts segment emerged as the largest segment in 2016 owing to increase in their adoption in pediatric cardiovascular surgeries for the treatment of CHDs
- The cardiovascular patches segment is anticipated to be the fastest growing with a growth rate of 6.4%
- Some of the major players operating in this market are Medtronic; Bard Peripheral Vascular; Terumo Cardiovascular Systems Corporation; W.L. Gore & Associates, Inc.; Getinge AB; CryoLife, Inc.; Edwards Lifesciences Corporation; Baxter; and Admedus.
Browse More Reports in Medical Device Industry:
Medical Device Cleaning Market – Growing adoption of medical assist devices coupled with rising economic crisis owing to speedy technological development are among the key trends stimulating market growth.
Dermatology Devices Market – Increasing prevalence of skin cancer and other skin diseases has significantly contributed to high demand for various dermatological diagnostic and treatment procedures in recent times, thereby spurring product demand.
Various initiatives by government organizations for the management of cardiovascular diseases is also expected to drive growth. For instance, American Heart Association funds research projects pertaining to CVD. It has funded some breakthrough projects in cardiology, such as techniques & standards for Cardiopulmonary Resuscitation (CPR), the first artificial heart valve, cholesterol inhibitors, implantable pacemakers, drug-eluting stents, and microsurgery. The foundation has funded more than USD 4 billion in the research projects since 1949.
Increase in the demand for effective therapies that reduce the incidence of adverse cardiac remodeling and help in regeneration or replacement of the myocardial tissues that get damaged during ischemic events is also anticipated to boost the cardiovascular repair and reconstruction devices market over the forecast period. Incidence of various CVD, such as heart attacks, stroke, and cardiac arrest, is rising owing to several risk factors such as changes in lifestyle, smoking, alcohol consumption, physical inactivity, improper nutrition, and obesity. According to American Heart Association, cardiovascular diseases accounted for about one in three deaths in the U.S. The medical cost of CHD is anticipated to increase by nearly 100% between 2013 to 2030. These factors are expected to boost growth over the forecast period.
Technological advancements in the fields of material sciences, interventional cardiology, and cryopreservation are also expected to drive the cardiovascular reconstruction devices market. The use of expanded PTFE for cardiovascular patches, introduction of transcatheter heart valves, and the development of minimally invasive technologies, such as transcatheter aortic valve implantation or transcatheter aortic valve replacement, are among few factors expected to boost growth over the forecast period. In addition, developments in cryopreservation techniques by key players such as CryoLife are among major technological advancements in cardiovascular therapies that are predicted to positively influence the market.
Grand View Research has segmented the cardiovascular repair and reconstruction devices market on the basis of product type and region:
Product Outlook (Revenue, USD Million, 2014 – 2025)
- Heart Valve Repair
- Cardiovascular Grafts
- Endovascular stent graft
- Hemodialysis access graft
- Peripheral vascular graft
- Cardiovascular Patches
- By Application
- Cardiac repair patches
- Atrial septal defect
- Common atrium
- Defects of the endocardial cushion
- Ventricular septal defect
- Tetralogy of Fallot
- Suture bleeding
- Vascular repair patches
- Carotid endarterectomy
- Anomalous connection of the pulmonary veins
- Transportation of the great vessels
- Reconstruction of the portal and superior mesenteric veins
- By Raw Material
- Synthetic patches
- Biological patches
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States